LH vs. DGX, DVA, CHE, CRVL, AMED, MD, AMN, CCRN, NTRA, and EXAS
Should you be buying Laboratory Co. of America stock or one of its competitors? The main competitors of Laboratory Co. of America include Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Natera (NTRA), and Exact Sciences (EXAS).
Laboratory Co. of America vs.
Laboratory Co. of America (NYSE:LH) and Quest Diagnostics (NYSE:DGX) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership.
In the previous week, Quest Diagnostics had 3 more articles in the media than Laboratory Co. of America. MarketBeat recorded 32 mentions for Quest Diagnostics and 29 mentions for Laboratory Co. of America. Laboratory Co. of America's average media sentiment score of 0.97 beat Quest Diagnostics' score of 0.63 indicating that Laboratory Co. of America is being referred to more favorably in the media.
Laboratory Co. of America received 83 more outperform votes than Quest Diagnostics when rated by MarketBeat users. Likewise, 63.91% of users gave Laboratory Co. of America an outperform vote while only 49.14% of users gave Quest Diagnostics an outperform vote.
95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are held by institutional investors. 0.8% of Laboratory Co. of America shares are held by company insiders. Comparatively, 8.2% of Quest Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Quest Diagnostics has lower revenue, but higher earnings than Laboratory Co. of America. Quest Diagnostics is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks.
Laboratory Co. of America has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500.
Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.2%. Quest Diagnostics pays an annual dividend of $3.20 per share and has a dividend yield of 1.8%. Laboratory Co. of America pays out 32.7% of its earnings in the form of a dividend. Quest Diagnostics pays out 40.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics has raised its dividend for 14 consecutive years. Quest Diagnostics is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Laboratory Co. of America presently has a consensus target price of $267.85, suggesting a potential upside of 10.56%. Quest Diagnostics has a consensus target price of $185.07, suggesting a potential upside of 3.93%. Given Laboratory Co. of America's stronger consensus rating and higher possible upside, analysts clearly believe Laboratory Co. of America is more favorable than Quest Diagnostics.
Quest Diagnostics has a net margin of 8.80% compared to Laboratory Co. of America's net margin of 5.73%. Laboratory Co. of America's return on equity of 15.29% beat Quest Diagnostics' return on equity.
Summary
Laboratory Co. of America beats Quest Diagnostics on 14 of the 22 factors compared between the two stocks.
Get Laboratory Co. of America News Delivered to You Automatically
Sign up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Laboratory Co. of America Competitors List
Related Companies and Tools
This page (NYSE:LH) was last updated on 5/1/2025 by MarketBeat.com Staff
Buy LH Stock Free LH Stock Alerts